US Stock MarketDetailed Quotes

MRVI Maravai LifeSciences

Watchlist
  • 5.920
  • +0.300+5.34%
Close Nov 27 16:00 ET
  • 5.920
  • 0.0000.00%
Post 20:01 ET
839.71MMarket Cap-3544P/E (TTM)

Maravai LifeSciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-7.27%13.14M
-9.17%17.43M
-109.95%-8.47M
-76.45%126.22M
-92.16%7.79M
-87.13%14.17M
-88.32%19.19M
-47.58%85.07M
45.42%535.98M
69.10%99.34M
Net income from continuing operations
-1,065.11%-175.96M
-21.34%-14.49M
-1,582.49%-22.68M
-128.20%-138.38M
-225.80%-109.98M
-115.15%-15.1M
-107.62%-11.94M
-100.92%-1.35M
4.56%490.66M
-31.22%87.43M
Operating gains losses
----
----
-318.56%-1.92M
----
----
----
----
322.12%878K
101.85%208K
--0
Depreciation and amortization
7.20%14.04M
23.30%14.55M
26.09%13.75M
28.02%48.78M
29.42%12.98M
32.16%13.1M
32.43%11.8M
17.84%10.91M
13.59%38.1M
10.45%10.03M
Deferred tax
--0
--0
--0
1,683.97%754.94M
10,807.86%764.75M
-159.91%-5.53M
-121.44%-2.76M
-111.50%-1.52M
-9.78%42.32M
-59.86%7.01M
Other non cash items
-37.55%1.96M
88.77%-545K
-47.35%963K
-7,443.03%-671.56M
-14,600.84%-671.68M
189.30%3.15M
34.33%-4.85M
169.65%1.83M
-140.23%-8.9M
42.35%4.63M
Change In working capital
-32.35%5.8M
-87.92%2.24M
-115.57%-10.64M
317.04%97.84M
115.09%2.38M
186.11%8.57M
266.71%18.55M
929.58%68.34M
74.48%-45.08M
84.30%-15.76M
-Change in receivables
206.41%9.84M
-126.73%-2.02M
-78.30%17.88M
478.93%84.4M
65.92%-8.79M
-44.94%3.21M
6,674.78%7.56M
3,817.05%82.41M
68.36%-22.27M
49.99%-25.77M
-Change in inventory
-1.74%-1.52M
-90.26%751K
124.24%820K
-93.14%649K
-111.33%-2.18M
35.34%-1.5M
188.60%7.71M
-381.68%-3.38M
143.84%9.46M
251.89%19.27M
-Change in prepaid assets
-87.38%439K
-100.93%-199K
103.17%730K
115.39%8.14M
138.64%6.38M
113.22%3.48M
269.42%21.29M
-1,014.26%-23.01M
-455.80%-52.87M
-374.63%-16.5M
-Change in payables and accrued expense
-155.41%-2.42M
147.99%7.57M
-215.87%-27.8M
194.47%20.39M
185.97%7.81M
-61.93%4.37M
-337.16%-15.77M
1,235.89%23.99M
349.01%6.93M
-237.50%-9.08M
-Change in other current liabilities
72.51%-298K
-40.51%-3.73M
89.38%-1.13M
-176.81%-15.98M
-108.61%-1.64M
-209.38%-1.08M
-241.92%-2.65M
-856.09%-10.6M
560.12%20.8M
2,090.80%19.05M
-Change in other working capital
-359.57%-244K
-132.51%-132K
-8.70%-1.15M
103.51%250K
129.54%808K
-75.77%94K
-76.69%406K
83.77%-1.06M
89.50%-7.12M
95.16%-2.74M
Cash from discontinued investing activities
Operating cash flow
-7.27%13.14M
-9.17%17.43M
-109.95%-8.47M
-76.45%126.22M
-92.16%7.79M
-87.13%14.17M
-88.32%19.19M
-47.58%85.07M
45.42%535.98M
69.10%99.34M
Investing cash flow
Cash flow from continuing investing activities
42.27%-8.96M
74.41%-6.18M
93.91%-4.24M
54.30%-122.31M
30.33%-12.9M
-165.44%-15.52M
-1,354.36%-24.16M
71.14%-69.73M
-353.29%-267.61M
-227.44%-18.52M
Net PPE purchase and sale
48.72%-7.96M
74.69%-6.18M
-2,752.50%-4.24M
-229.61%-52.69M
-152.55%-12.9M
-139.99%-15.52M
-1,370.50%-24.43M
105.82%160K
-11.77%-15.99M
9.67%-5.11M
Net business purchase and sale
--0
--0
--0
70.79%-69.62M
--0
--0
--109K
70.80%-69.73M
-298.70%-238.35M
---133K
Net other investing changes
----
----
----
----
----
----
----
---159K
---13.28M
----
Cash from discontinued investing activities
Investing cash flow
42.27%-8.96M
74.41%-6.18M
93.91%-4.24M
54.30%-122.31M
30.33%-12.9M
-165.44%-15.52M
-1,354.36%-24.16M
71.14%-69.73M
-353.29%-267.61M
-227.44%-18.52M
Financing cash flow
Cash flow from continuing financing activities
3.32%809K
100.53%228K
97.08%-560K
67.42%-61.09M
100.71%470K
102.09%783K
0.64%-43.13M
52.60%-19.21M
-17.89%-187.5M
-33.37%-66.12M
Net issuance payments of debt
-2.43%-1.52M
-5.75%-1.51M
-10.66%-1.51M
-6.10%-5.77M
-10.44%-1.5M
-9.12%-1.48M
-4.85%-1.43M
0.00%-1.36M
9.33%-5.44M
9.33%-1.36M
Proceeds from stock option exercised by employees
----
----
----
-100.85%-20K
-196.16%-351K
----
----
----
37.98%2.36M
-3.95%365K
Net other financing activities
96.75%3.81M
104.16%1.74M
105.29%945K
70.01%-55.3M
103.57%2.32M
105.26%1.94M
2.07%-41.71M
55.25%-17.85M
-19.16%-184.42M
-34.40%-65.13M
Cash from discontinued financing activities
Financing cash flow
3.32%809K
100.53%228K
97.08%-560K
67.42%-61.09M
100.71%470K
102.09%783K
0.64%-43.13M
52.60%-19.21M
-17.89%-187.5M
-33.37%-66.12M
Net cash flow
Beginning cash position
-1.21%573.17M
-10.60%561.69M
-9.04%574.96M
14.67%632.14M
-6.13%579.61M
5.36%580.18M
45.61%628.27M
14.67%632.14M
133.41%551.27M
12.69%617.45M
Current changes in cash
973.20%4.99M
123.87%11.48M
-243.36%-13.27M
-170.70%-57.18M
-131.60%-4.64M
-100.86%-571K
-140.35%-48.1M
96.77%-3.87M
-74.34%80.87M
318.93%14.69M
Effect of exchange rate changes
----
----
----
--0
----
----
----
----
--0
----
End cash Position
-0.25%578.16M
-1.21%573.17M
-10.60%561.69M
-9.04%574.96M
-9.04%574.96M
-6.13%579.61M
5.36%580.18M
45.61%628.27M
14.67%632.14M
14.67%632.14M
Free cash flow
313.43%3.55M
234.37%7.88M
-118.30%-14.13M
-88.31%60.67M
-109.67%-9.01M
-101.60%-1.66M
-103.61%-5.87M
-51.61%77.21M
46.69%518.89M
75.41%93.12M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -7.27%13.14M-9.17%17.43M-109.95%-8.47M-76.45%126.22M-92.16%7.79M-87.13%14.17M-88.32%19.19M-47.58%85.07M45.42%535.98M69.10%99.34M
Net income from continuing operations -1,065.11%-175.96M-21.34%-14.49M-1,582.49%-22.68M-128.20%-138.38M-225.80%-109.98M-115.15%-15.1M-107.62%-11.94M-100.92%-1.35M4.56%490.66M-31.22%87.43M
Operating gains losses ---------318.56%-1.92M----------------322.12%878K101.85%208K--0
Depreciation and amortization 7.20%14.04M23.30%14.55M26.09%13.75M28.02%48.78M29.42%12.98M32.16%13.1M32.43%11.8M17.84%10.91M13.59%38.1M10.45%10.03M
Deferred tax --0--0--01,683.97%754.94M10,807.86%764.75M-159.91%-5.53M-121.44%-2.76M-111.50%-1.52M-9.78%42.32M-59.86%7.01M
Other non cash items -37.55%1.96M88.77%-545K-47.35%963K-7,443.03%-671.56M-14,600.84%-671.68M189.30%3.15M34.33%-4.85M169.65%1.83M-140.23%-8.9M42.35%4.63M
Change In working capital -32.35%5.8M-87.92%2.24M-115.57%-10.64M317.04%97.84M115.09%2.38M186.11%8.57M266.71%18.55M929.58%68.34M74.48%-45.08M84.30%-15.76M
-Change in receivables 206.41%9.84M-126.73%-2.02M-78.30%17.88M478.93%84.4M65.92%-8.79M-44.94%3.21M6,674.78%7.56M3,817.05%82.41M68.36%-22.27M49.99%-25.77M
-Change in inventory -1.74%-1.52M-90.26%751K124.24%820K-93.14%649K-111.33%-2.18M35.34%-1.5M188.60%7.71M-381.68%-3.38M143.84%9.46M251.89%19.27M
-Change in prepaid assets -87.38%439K-100.93%-199K103.17%730K115.39%8.14M138.64%6.38M113.22%3.48M269.42%21.29M-1,014.26%-23.01M-455.80%-52.87M-374.63%-16.5M
-Change in payables and accrued expense -155.41%-2.42M147.99%7.57M-215.87%-27.8M194.47%20.39M185.97%7.81M-61.93%4.37M-337.16%-15.77M1,235.89%23.99M349.01%6.93M-237.50%-9.08M
-Change in other current liabilities 72.51%-298K-40.51%-3.73M89.38%-1.13M-176.81%-15.98M-108.61%-1.64M-209.38%-1.08M-241.92%-2.65M-856.09%-10.6M560.12%20.8M2,090.80%19.05M
-Change in other working capital -359.57%-244K-132.51%-132K-8.70%-1.15M103.51%250K129.54%808K-75.77%94K-76.69%406K83.77%-1.06M89.50%-7.12M95.16%-2.74M
Cash from discontinued investing activities
Operating cash flow -7.27%13.14M-9.17%17.43M-109.95%-8.47M-76.45%126.22M-92.16%7.79M-87.13%14.17M-88.32%19.19M-47.58%85.07M45.42%535.98M69.10%99.34M
Investing cash flow
Cash flow from continuing investing activities 42.27%-8.96M74.41%-6.18M93.91%-4.24M54.30%-122.31M30.33%-12.9M-165.44%-15.52M-1,354.36%-24.16M71.14%-69.73M-353.29%-267.61M-227.44%-18.52M
Net PPE purchase and sale 48.72%-7.96M74.69%-6.18M-2,752.50%-4.24M-229.61%-52.69M-152.55%-12.9M-139.99%-15.52M-1,370.50%-24.43M105.82%160K-11.77%-15.99M9.67%-5.11M
Net business purchase and sale --0--0--070.79%-69.62M--0--0--109K70.80%-69.73M-298.70%-238.35M---133K
Net other investing changes -------------------------------159K---13.28M----
Cash from discontinued investing activities
Investing cash flow 42.27%-8.96M74.41%-6.18M93.91%-4.24M54.30%-122.31M30.33%-12.9M-165.44%-15.52M-1,354.36%-24.16M71.14%-69.73M-353.29%-267.61M-227.44%-18.52M
Financing cash flow
Cash flow from continuing financing activities 3.32%809K100.53%228K97.08%-560K67.42%-61.09M100.71%470K102.09%783K0.64%-43.13M52.60%-19.21M-17.89%-187.5M-33.37%-66.12M
Net issuance payments of debt -2.43%-1.52M-5.75%-1.51M-10.66%-1.51M-6.10%-5.77M-10.44%-1.5M-9.12%-1.48M-4.85%-1.43M0.00%-1.36M9.33%-5.44M9.33%-1.36M
Proceeds from stock option exercised by employees -------------100.85%-20K-196.16%-351K------------37.98%2.36M-3.95%365K
Net other financing activities 96.75%3.81M104.16%1.74M105.29%945K70.01%-55.3M103.57%2.32M105.26%1.94M2.07%-41.71M55.25%-17.85M-19.16%-184.42M-34.40%-65.13M
Cash from discontinued financing activities
Financing cash flow 3.32%809K100.53%228K97.08%-560K67.42%-61.09M100.71%470K102.09%783K0.64%-43.13M52.60%-19.21M-17.89%-187.5M-33.37%-66.12M
Net cash flow
Beginning cash position -1.21%573.17M-10.60%561.69M-9.04%574.96M14.67%632.14M-6.13%579.61M5.36%580.18M45.61%628.27M14.67%632.14M133.41%551.27M12.69%617.45M
Current changes in cash 973.20%4.99M123.87%11.48M-243.36%-13.27M-170.70%-57.18M-131.60%-4.64M-100.86%-571K-140.35%-48.1M96.77%-3.87M-74.34%80.87M318.93%14.69M
Effect of exchange rate changes --------------0------------------0----
End cash Position -0.25%578.16M-1.21%573.17M-10.60%561.69M-9.04%574.96M-9.04%574.96M-6.13%579.61M5.36%580.18M45.61%628.27M14.67%632.14M14.67%632.14M
Free cash flow 313.43%3.55M234.37%7.88M-118.30%-14.13M-88.31%60.67M-109.67%-9.01M-101.60%-1.66M-103.61%-5.87M-51.61%77.21M46.69%518.89M75.41%93.12M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data